ALLMedicine™ Glomerulonephritis Center

May 21st, 2022 - Losing-salt tubulopathies, such as Bartter syndrome, are rare and usually inherited due to mutations of tubular reabsorption channels of the nephrons. Despite its scarcity, some cases of acquired losing-salt tubulopathies have been described. In t...

May 20th, 2022 - This study evaluates participants with known or suspected immunologically-mediated kidney diseases, including but not limited to nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with other s...

May 20th, 2022 - Renal resistive index (RRI) measured by Doppler sonography is a marker of microvascular status and it is associated with changes in renal function. Aim of the study was to assess RRI in biopsy-proven tubulointerstitial nephritis (TIN) in patients ...

May 17th, 2022 - Practice Essentials Homocystinuria is an inherited autosomal recessive defect in methionine metabolism that is caused by a deficiency in cystathionine synthase.[1] This defect leads to a multisystemic disorder of the connective tissue, muscles, CN...

May 17th, 2022 - Practice Essentials Homocystinuria is an inherited autosomal recessive defect in methionine metabolism that is caused by a deficiency in cystathionine synthase. [1] This defect leads to a multisystemic disorder of the connective tissue, muscles, C...

Feb 3rd, 2022 - To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items ...

Sep 27th, 2021 - A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020.|2021|Usui J,Kawashima S,Sada KE,Miyawaki Y,Nakazawa D,|diagnosis,drug therapy,

Sep 25th, 2021 - The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (G...

Apr 22nd, 2016 - Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014.|2016|Arimura Y,Muso E,Fujimoto S,Hasegawa M,Kaname S,|standards,diagnosis,epidemiology,physiopathology,therapy,standards,

Oct 12th, 2012 - Kidney Disease: Improving Global Outcomes (KDIGO) recently published the clinical practice guideline on glomerulonephritis (GN) to assist the practitioner caring for patients with GN. Chapter 4 of the guideline focuses on managing children aged 1-...

May 20th, 2022 - This study evaluates participants with known or suspected immunologically-mediated kidney diseases, including but not limited to nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with other s...

Mar 15th, 2022 - Chronic kidney disease is a common disease that affects health seriously. In some regions of China, the morbidity of this kind of disease is as high as 10.8%. Primary glomerulopathy is one of the pathogenesis of chronic kidney disease, which occup...

Mar 9th, 2022 - This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN) on...

Mar 2nd, 2022 - IgA nephropathy (IgAN) is a common cause of glomerulonephritis and a major cause of end stage renal disease in up to 20-40% of patients. However, its prognosis still cannot be accurately predicted due to the high heterogenicity of clinical present...

Feb 9th, 2022 - This trial will evaluate the efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or ianalumab given every 12 weeks (q12w) compared to placebo, in combination with SoC, in adult participants with active LN ...

Nov 5th, 2021 - At any given time, an estimated 15% of the US adult population has chronic kidney disease (CKD). It manifests as reduced kidney function to below 60% of its normal range (estimated glomerular filtration rate < 60 mL/min/1.73 m2) or by spillage of ...

Aug 12th, 2021 - (Reuters) - Three new conditions reported by a small number of people after vaccination with COVID-19 shots from Pfizer and Moderna are being studied to assess if they may be possible side-effects, Europe's drugs regulator said on Wednesday. Eryth...

Jul 19th, 2021 - NEW YORK (Reuters Health) - Transcatheter aortic-valve implantation (TAVI) is safe and effective for patients with inflammatory bowel disease (IBD), according to what is believed to be the first study to assess TAVI outcomes in this patient popula...

Jun 9th, 2021 - A first-in-class oral inhibitor of the alternative complement pathway that drives the pathogenesis of primary glomerulonephritis, iptacopan (LNP023, Novartis), is showing early promise as the first targeted therapy for the treatment of IgA nephrop...

Jun 1st, 2021 - A reduced dose of prednisolone plus rituximab was as effective as a conventionally high dose in treating patients with newly diagnosed antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis, according to a new Japanese study, along with.